Navigation Links
RainTree Oncology Services Announces Service Agreement With Diplomat Specialty Pharmacy
Date:12/8/2011

SAN DIEGO, Dec. 8, 2011 /PRNewswire/ -- RainTree Oncology Services (RainTree Oncology), a privately-held provider of oral oncologic drug acquisition and management services, today announced it has signed a service agreement with Diplomat Specialty Pharmacy (Diplomat), the nation's largest privately-owned specialty pharmacy providing medication management and clinical services. The agreement will enable the Company to provide community oncology practices with better access to crucial oral oncology drugs, clinical programs and adherence-enhancing medication management programs.

"Diplomat is not only one of the nation's largest dispensers of many oral oncolytics, such as Revlimid and Zytiga, but also brings impressive oncology-specific programs and data collection capabilities," said Mike Martin, president and chief executive officer of RainTree Oncology. "Their resources align with our physician centric, patient focused initiative to provide important data to community oncology practices. This will enable our customers to better support cancer care through analysis of cancer patient compliance, adherence and outcomes."

"We are honored to be chosen by Raintree to be their specialty pharmacy partner," said Phil Hagerman, Diplomat's president and chief executive officer.  "Working in close partnership with Raintree will facilitate enhanced services to Raintree physicians and improved outcomes for their patients. This model will secure access to complex oral oncolytics as well as implement drug-specific algorithms that will help mimic clinical trial efficacy."            

In the United States, community oncologists provide care for the majority of cancer patients. Increasingly, changes in healthcare economics are impacting how these practices operate, putting pressure on their ability to deliver essential services to their patients. Oral drug acquisition and management can be particularly problematic as the drugs are expensive and often are not fully reimbursed.

RainTree Oncology is building a network of community oncologists through which members will obtain pharmaceuticals at contracted prices - a savings that could be passed onto the patient or used to enhance patient services. In addition, RainTree Oncology will facilitate the implementation of in-practice pharmacies for practices that do not have one, providing an added convenience for patients and a key source of information for physicians.

Using technology tools provided by RainTree, practice pharmacists will be able to track both the prescribing and fulfillment of oral oncology medications in practices, as well as patient utilization of these drugs. Practice physicians and administrators can then use the information to elevate practice care and improve operations.

About RainTree Oncology Services
RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance state of the art in oral oncology. RainTree Oncology is physician centric, patient focused and community minded. For more information about RainTree Oncology Services: www.raintreeoncology.com.

About Diplomat Specialty Pharmacy
Michigan-based Diplomat Specialty Pharmacy, founded in 1975, serves patients nationwide as the country's largest privately held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Diplomat creates unique programs with specialty distribution at retail focusing on improving adherence and the patient experience, as well as creating exclusive distribution models for its pharmaceutical partners. Learn more about Keeping Patients Healthier…Longer® at www.diplomatpharmacy.com


'/>"/>
SOURCE RainTree Oncology Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The US Oncology Network to Present Webinar on Value-Based Reimbursement
2. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
3. Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011
4. OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib)
5. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
6. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
7. Analytical Tool - Antibodies and Peptides in Oncology
8. Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting
9. Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care
10. Caliper Launches New Platform for Drug Safety Prediction and Oncology Research
11. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):